1.
Richardson P, Htut M, Scott E, Prada CP, Gupta I. Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile. Haematologica 2025;110(2):488-492; https://doi.org/10.3324/haematol.2024.285380.